68
Predictors of early androgen deprivation treatment failure in prostate cancer with bone metastases.
Varenhorst E, Klaff R, Berglund A, Hedlund PO, Sandblom G. Scandinavian Prostate Cancer Group (SPCG) Trial No. 5.
Cancer Med. 2016
SPCG-5Publications
All trial summaries
Read abstracts below
67
Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: Analysis of the placebo arm of the SPCG-6 study.
Thomsen FB, Brasso K, Berg KD, Gerds TA, Johansson JE, Angelsen A, Tammela TL, Iversen P. Scandinavian Prostate Cancer Group.
Ann Oncol. 2016
SPCG-6
66
Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer; long-term follow up of the SPCG-6 study.
Thomsen FB, Brasso K, Christensen IJ, Johansson JE, Angelsen A, Tammela TL, Iversen P. Scandinavian Prostate Cancer Group.
Eur J Cancer. 2015
SPCG-6
65
Prevention of bone metastases in patients with high-risk nonmetastatic prostate cancer treated with zoledronic acid: Efficacy and safety results of the zometa European study (ZEUS).
Wirth M, Tammela T, Cicalese V, Veiga FG, Delaere K, Miller K, TubaroA, Schulze M, Debruyne F, Huland H, Patel A, Lecouvet F, Caris C, Witjes W.
Eur Urol. 2015
Posaproca/SPCG
64
Radical prostatectomy or watchful waiting in early prostate cancer.
Bill-Axelson A, Holmberg L, Garmo H, Rider JR, Taari K, Busch C, Nordling S, Häggman M, Andersson SO, Spångberg A, Andrén O, Palmgren J, Steineck G, Adami HO, Johansson JE.
N Engl J Med. 2014
SPCG-4
63
Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial.
Bill-Axelson A, Garmo H, Holmberg L, Johansson JE, Adami HO, Steineck G, Johansson E, Rider JR.
Eur Urol. 2013
SPCG-4
62
Late radiation effects to the rectum and anus after treatment for prostate cancer: validity of the LENT/SOMA score.
Lund JÅ, Kaasa S, Wibe A, Widmark A, Fransson P.
Acta Oncol. 2013
Posaproca/SPCG
61
Results from the Scandinavian Prostate Cancer Group Trial Number 4: A randomized controlled trial of radical prostatectomy versus watchful waiting.
Holmberg L, Bill-Axelson A, Steineck G, Garmo H, Palmgren J, Johansson E, Adami HO, Johansson JE.
J Natl Cancer Inst Monogr. 2012
SPCG-4
60
Toxicity in patients receiving adjuvant docetaxel + hormonal treatment after radical radiotherapy for intermediate or high-risk prostate cancer: a preplanned safety report of the SPCG-13 trial
Kellokumpu-Lehtinen PL, Hjälm-Eriksson M, Thellenberg-Karlsson C, Åström L, Franzen L, Marttila T, Seke M, Taalikka M, Ginman C
Prostate Cancer Prostatic Dis. 2012
SPCG-13
59
Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group-4 randomized trial.
Vickers A, Bennette C, Steineck G, Adami HO, Johansson JE, Bill-Axelson A, Palmgren J, Garmo H, Holmberg L.
Eur Urol. 2012
SPCG-4